1-20 of 22
Section: Cancer Immunity
Journal Article
Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer Get access
Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxae110, https://doi.org/10.1093/cei/uxae110
Published: 13 March 2025
Journal Article
Dynamic changes of host immune response during Helicobacter pylori-induced gastric cancer development Get access
Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxae109, https://doi.org/10.1093/cei/uxae109
Published: 09 March 2025
Journal Article
Peripheral immune biomarkers associated with response to adoptive cell therapy with tumor infiltrating lymphocytes Get access
Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxaf010, https://doi.org/10.1093/cei/uxaf010
Published: 18 February 2025
Journal Article
Exploring the relation between TGF-β pathway activity and response to checkpoint inhibition in patients with metastatic melanoma
Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxae108, https://doi.org/10.1093/cei/uxae108
Published: 30 November 2024
Journal Article
sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance Get access
Clinical and Experimental Immunology, Volume 219, Issue 1, 2025, uxae084, https://doi.org/10.1093/cei/uxae084
Published: 07 October 2024
Journal Article
Increased IFN-β indicates better survival in hepatocellular carcinoma treated with radiotherapy Get access
Clinical and Experimental Immunology, Volume 218, Issue 2, November 2024, Pages 188–198, https://doi.org/10.1093/cei/uxae075
Published: 26 August 2024
Journal Article
Screening and anti-angiogenesis activity of Chiloscyllium plagiosum anti-human VEGFR2 single-domain antibody Get access
Clinical and Experimental Immunology, Volume 218, Issue 2, November 2024, Pages 177–187, https://doi.org/10.1093/cei/uxae060
Published: 19 July 2024
Journal Article
Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
Clinical and Experimental Immunology, Volume 216, Issue 2, May 2024, Pages 159–171, https://doi.org/10.1093/cei/uxae007
Published: 08 February 2024
Journal Article
FGL1 in plasma extracellular vesicles is correlated with clinical stage of lung adenocarcinoma and anti-PD-L1 response
Clinical and Experimental Immunology, Volume 216, Issue 1, April 2024, Pages 68–79, https://doi.org/10.1093/cei/uxad137
Published: 26 December 2023
Journal Article
Immunological dynamic characteristics in acute myeloid leukemia predict the long-term outcomes and graft-versus host-disease occurrences post-transplantation
Clinical and Experimental Immunology, Volume 215, Issue 2, February 2024, Pages 148–159, https://doi.org/10.1093/cei/uxad123
Published: 16 November 2023
Journal Article
Toxicity spectrum and risk factors for chemo-immunotherapy in locally advanced or metastatic lung cancer
Clinical and Experimental Immunology, Volume 214, Issue 2, November 2023, Pages 162–169, https://doi.org/10.1093/cei/uxad105
Published: 11 September 2023
Journal Article
Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer
Clinical and Experimental Immunology, Volume 214, Issue 1, October 2023, Pages 50–60, https://doi.org/10.1093/cei/uxad080
Published: 17 July 2023
Journal Article
Dissecting T-cell heterogeneity in esophageal squamous cell carcinoma reveals the potential role of LAIR2 in antitumor immunity
Clinical and Experimental Immunology, Volume 214, Issue 1, October 2023, Pages 36–49, https://doi.org/10.1093/cei/uxad073
Published: 09 July 2023
Journal Article
Efficacy of anti-programmed cell death protein 1 monoclonal antibody combined with bevacizumab and/or Pseudomonas aeruginosa injection in transplanted tumor of mouse forestomach carcinoma cell gastric cancer in mice and its mechanism in regulating tumor immune microenvironment
Clinical and Experimental Immunology, Volume 213, Issue 3, September 2023, Pages 328–338, https://doi.org/10.1093/cei/uxad069
Published: 01 July 2023
Journal Article
Therapeutic hyperthermia regulates complement C3 activation and suppresses tumor development through HSPA5/NFκB/CD55 pathway in nasopharyngeal carcinoma
Clinical and Experimental Immunology, Volume 213, Issue 2, August 2023, Pages 221–234, https://doi.org/10.1093/cei/uxad060
Published: 30 May 2023
Journal Article
Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy
Clinical and Experimental Immunology, Volume 212, Issue 3, June 2023, Pages 239–248, https://doi.org/10.1093/cei/uxad036
Published: 26 March 2023
Journal Article
Tumor gene signatures that correlate with release of extracellular vesicles shape the immune landscape in head and neck squamous cell carcinoma
Clinical and Experimental Immunology, Volume 213, Issue 1, July 2023, Pages 102–113, https://doi.org/10.1093/cei/uxad019
Published: 08 February 2023
Journal Article
miR-132-3p regulates antibody-mediated complement-dependent cytotoxicity in colon cancer cells by directly targeting CD55
Clinical and Experimental Immunology, Volume 211, Issue 1, January 2023, Pages 57–67, https://doi.org/10.1093/cei/uxac120
Published: 26 December 2022
Journal Article
Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3
Clinical and Experimental Immunology, Volume 210, Issue 3, December 2022, Pages 309–320, https://doi.org/10.1093/cei/uxac102
Published: 12 November 2022
Journal Article
Discovery of efficacy biomarkers for non-small cell lung cancer with first-line anti-PD-1 immunotherapy by data-independent acquisition mass spectrometry
Clinical and Experimental Immunology, Volume 208, Issue 1, April 2022, Pages 60–71, https://doi.org/10.1093/cei/uxac021
Published: 03 March 2022
